Latest filing published 27 Dec 2006 for La Jolla Pharmaceutical Co, €11k.
Insider track record
No signal scores available.
Matthew D. Linnik: trading record in brief
Matthew D. Linnik appears in our data through filings on La Jolla Pharmaceutical Co shares, published by SEC (Form 4). The record holds 6 filings, for trades running from 14 December 2006 to 27 December 2006.
The open-market record consists of 2 sales worth €12k, with no purchase.
The newest entry dates from 27 December 2006: an open-market sale of €11k, in La Jolla Pharmaceutical Co. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Matthew D. Linnik
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000 shares@ US$2.88Common StockSEC:0001209191-06-067122:0
- 365 shares@ US$3.03Common StockSEC:0001209191-06-067122:1
- 3,500 shares@ US$3.01Common StockSEC:0001209191-06-066303:0
- 2,500 shares@ US$3.00Common StockSEC:0001209191-06-066303:1
- 7,500 shares@ US$3.02Common StockSEC:0001209191-06-065620:1
5 of 5 declarations
